Intraperitoneal Lymphokine-Activated Killer Cell/Interleukin-2 Therapy in Patients With Intra- abdominal Cancer: Immunologic Considerations

Verfasser / Beitragende:
[Walter J. Urba, Jeffrey W. Clark, Ronald G. Steis, Michael A. Bookman, John W. Smith, Suzanne Beckner, Annette E. Maluish, Jeffrey L. Rossio, Helen Rager, John R. Ortaldo, Dan L. Longo]
Ort, Verlag, Jahr:
1989
Enthalten in:
JNCI: Journal of the National Cancer Institute, 81/8(1989-04-19), 602-611
Format:
Artikel (online)
ID: 396006876